Funded Projects
Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.
Project # | Project Title | Research Focus Area | Research Program | Administering IC | Institution(s) | Investigator(s) | Location(s) | Year Awarded |
---|---|---|---|---|---|---|---|---|
1OT2DA061065-01
Show Summary |
Promoting Wellness among Native Americans in Urban Areas | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | MONTANA CONSORTIUM FOR URBAN INDIAN HEALTH | GREEN, BRANDN | Helena, MT | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1OT2DA061144-01
Show Summary |
Development and Implementation of a Community-Led Research Program in the Utah Navajo Health System | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | UTAH NAVAJO HEALTH SYSTEM, INC. | HENDY, RICK (contact); KELLEY, ALAN TAYLOR | Montezuma Creek, UT | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1OT2DA061064-01
Show Summary |
Partnering to Achieve Wellness for Native Americans through Indigenous Knowledge (PAWNIK) | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | RAND CORPORATION | D'AMICO, ELIZABETH J (contact); JOHNSON, CARRIE | Pittsburgh, PA | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2)
NOFO Number: OTA-23-008 |
||||||||
1UG3DA059278-01A1
Show Summary |
Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | SPARIAN BIOSCIENCES, INC. | REICH, JEFFREY | New York, NY | 2024 |
NOFO Title: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
NOFO Number: PAR-22-200 |
||||||||
4UH3DA050325-03
Show Summary |
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | PENN STATE HEALTH HERSHEY MEDICAL CENTER | GRIGSON, PATRICIA SUE (contact); BRICK, TIMOTHY R; BUNCE, SCOTT C; NYLAND, JENNIFER E | Hershey, PA | 2024 |
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
NOFO Number: RFA-DA-19-002 |
||||||||
1R61DA061335-01
Show Summary |
Development and Evaluation of a Mobile Health Intervention for Co-Morbid Opioid Use Disorder and Posttraumatic Stress Disorder During Community Re-entry | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | UNIVERSITY OF RHODE ISLAND | WEISS, NICOLE HOLLAND | Kingston, RI | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R61DA062351-01
Show Summary |
A Bundled Intervention to End Opioid Overdoses by Increasing Treatment Uptake Post Emergency Department Discharge | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | UNIVERSITY OF ALABAMA AT BIRMINGHAM | LI, LI | Birmingham, AL | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R01DA061771-01
Show Summary |
Pharmacological targeting of nascent modulators of opioid signaling | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | UNIVERSITY OF FLORIDA | MARTEMYANOV, KIRILL A | Gainesville, FL | 2024 |
NOFO Title: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-063 |
||||||||
1R34DA062260-01
Show Summary |
Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD adherence to adolescents with OUD | New Strategies to Prevent and Treat Opioid Addiction | NIDA | MARYLAND TREATMENT CENTERS, INC. | WENZEL, KEVIN R (contact); FISHMAN, MARC | Baltimore, MD | 2024 | |
NOFO Title: Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional)
NOFO Number: RFA-DA-25-031 |
||||||||
1OT2DA061112-01
Show Summary |
Heal(th) From Within: A Research Collaborative to Share our Journeys to Wellness | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | ALASKA NATIVE TRIBAL HEALTH CONSORTIUM | FORD, TARA (contact); JESSEN, CORNELIA M | Anchorage, AK | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1OT2DA061063-01
Show Summary |
GATHER: Growing a Tribal Healing Effort through Research | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | UNIVERSITY OF WASHINGTON | PARKER, MYRA ELIZABETH (contact); MAGARATI, RATNA MAYA | Seattle, WA | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2)
NOFO Number: OTA-23-008 |
||||||||
1R43DA060033-01A1
Show Summary |
Xylazine and opioid overdose mitigation therapy using decoy receptor biomimetic nanoparticles, NarcoBond platform | Cross-Cutting Research | Small Business Programs | NIDA | CIBOTS, INC. | ESMAELI-AZAD, BABAK | San Diego, CA | 2024 |
NOFO Title: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-23-230 |
||||||||
1U01DA060704-01A1
Show Summary |
Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER | FRANCE, CHARLES P | San Antonio, TX | 2024 |
NOFO Title: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
NOFO Number: PAR-22-202 |
||||||||
4R33DA057660-02
Show Summary |
Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS) | Cross-Cutting Research | Translating Data 2 Action to Prevent Overdose | NIDA | INDIANA UNIVERSITY INDIANAPOLIS | AALSMA, MATTHEW (contact); RAY, BRADLEY; REDA, KHAIRI | Indianapolis, IN | 2024 |
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051 |
||||||||
1R61DA061377-01
Show Summary |
Impact of collaborative care for pregnant persons with opioid use disorder in low-resource obstetric settings | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION | KRANS, ELIZABETH E (contact); JARLENSKI, MARIAN PATRICIA | Pittsburgh, PA | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R33DA061260-01
Show Summary |
Efficacy and implementation considerations for a peer-led motivational interviewing intervention to promote uptake of drug checking services and safer drug use behaviors to reduce overdose | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | UNIVERSITY OF CALIFORNIA SAN DIEGO | STRATHDEE, STEFFANIE A (contact); BORQUEZ, ANNICK | La Jolla, CA | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-054 |
||||||||
1R21DA062022-01
Show Summary |
Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER | TUNSTALL, BRENDAN | Memphis, TN | 2024 |
NOFO Title: HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-064 |
||||||||
1OT2DA061140-01
Show Summary |
Building iCRISP: Indigenous Community-Informed Research Infrastructure to address Substance Misuse and Pain Management | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | LUMBEE LAND DEVELOPMENT, INC. | BEASLEY, CHERRY M (contact); BELL, RONNY A; IRBY, MEGAN; PENZIEN, DONALD BAIRD | Pembroke, NC | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007 |
||||||||
1OT2DA062969-01
Show Summary |
Hawaii N CREW Research Resource Center | Translation of Research to Practice for the Treatment of Opioid Addiction | Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain | NIDA | UNIVERSITY OF HAWAII AT MANOA | GOEBERT, DEBORAH A (contact); ONOYE, JANE | Honolulu, HI | 2024 |
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain Native Research Resource Network (OT2)
NOFO Number: OTA-23-008 |
||||||||
1R21DA061660-01
Show Summary |
Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach | Cross-Cutting Research | NIDA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | KRAWCZYK, NOA (contact); JORDAN, ASHLY ELIZABETH | New York, NY | 2024 | |
NOFO Title: Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
NOFO Number: PAR-22-027 |
||||||||
4UH3DA048767-03
Show Summary |
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics | Novel Therapeutic Options for Opioid Use Disorder and Overdose | Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose | NIDA | EICOSIS, LLC | CORTES-PUCH, IRENE (contact); HAMMOCK, BRUCE D | Davis, CA | 2024 |
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
NOFO Number: RFA-DA-19-002 |
||||||||
1R61DA059035-01A1
Show Summary |
Together Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | NDRI-USA, INC. | ARONSON, IAN DAVID | New York, NY | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R61DA062321-01
Show Summary |
Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management (SUPPORT-MOM) | Translation of Research to Practice for the Treatment of Opioid Addiction | Optimizing the Quality, Reach, and Impact of Addiction Services | NIDA | WASHINGTON UNIVERSITY IN ST. LOUIS | KELLY, JEANNIE CHEN (contact); BAUMANN WALKER, ANA | St. Louis, MO | 2024 |
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053 |
||||||||
1R61DA061831-01
Show Summary |
Engaging People Who Use Drugs in Harm Reduction Service Delivery: An Intravention to Reduce Risk of HIV, HCV, Overdose, and Injection-related Infections in Rural Appalachia | New Strategies to Prevent and Treat Opioid Addiction | NIDA | UNIVERSITY OF KENTUCKY | YOUNG, APRIL MARIE | Lexington, KY | 2024 | |
NOFO Title: Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
NOFO Number: RFA-DA-24-036 |
||||||||
1R21DA062256-01
Show Summary |
The Youth Empowerment Study (YES) | New Strategies to Prevent and Treat Opioid Addiction | NIDA | BOSTON MEDICAL CENTER | BAGLEY, SARAH M (contact); GREEN, TRACI C | Boston, MA | 2024 | |
NOFO Title: Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed)
NOFO Number: RFA-DA-25-030 |